Compare Humana Inc (HUM) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Strategy Inc. — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Strategy Inc. trades at $154.34 (market cap $60.40B). The key difference: Strategy Inc. is the larger of the two by market cap, and Humana Inc pays a 0.91% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Strategy Inc. for 112 Days on average.
| HUM | MSTR | |
|---|---|---|
Market Cap | $46.49B | $60.40B |
Volume | 2,567,704 | 23,421,830 |
Sector | Health | Technology |
52-Week High | $409.85 | $320.29 |
52-Week Low | $163.67 | $82.31 |
Typical Hold Time | 51 Days | 112 Days |
Enterprise Value | $53.84B | $79.16B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
MSTR stock trades at $151.47, down 1.24% on the day, with a bullish technical signal and key support at $148. The company reported a net loss of $3.85 billion in 2025, with a negative net income margin of -6,102.96%, while analyst consensus remains positive with a $253.36 price target. Recent news highlights Citigroup doubling its price target to $240 amid a 35.67% one-month stock surge.
Outlook is mixed: strong analyst buy ratings and Bitcoin-linked optimism offer upside potential, but persistent losses, high debt, and volatile cash flows pose significant risks. Investors should weigh the bullish sentiment against fundamental weaknesses in profitability and substantial financial leverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
